As of 2026-03-15, the Relative Valuation of CureVac NV (CVAC) is 4.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.66 USD, the upside of CureVac NV based on Relative Valuation is 6.1%.
The range of the Relative Valuation is 1.80 - 9.37 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 14.1x | 12.0x |
| Forward P/E multiples | 16.6x - 18.7x | 17.6x |
| Fair Price | 1.80 - 9.37 | 4.95 |
| Upside | -61.3% - 101.1% | 6.1% |
| Date | P/E |
| 2026-01-05 | 7.01 |
| 2026-01-02 | 7.03 |
| 2025-12-31 | 6.80 |
| 2025-12-30 | 6.74 |
| 2025-12-29 | 6.50 |
| 2025-12-26 | 6.47 |
| 2025-12-24 | 6.48 |
| 2025-12-23 | 6.33 |
| 2025-12-22 | 6.20 |
| 2025-12-19 | 6.26 |
| 2025-12-18 | 6.44 |
| 2025-12-17 | 6.21 |
| 2025-12-16 | 7.25 |
| 2025-12-15 | 7.52 |